Lig1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LIG1 (DNA Ligase 1) is the primary DNA ligase required for DNA replication in eukaryotic cells. It catalyzes the formation of phosphodiester bonds between adjacent 3'-hydroxy and 5'-phosphate ends on double-stranded DNA, playing essential roles in DNA replication, repair, and recombination.
DNA Ligase 1 is specifically involved in:
- Okazaki Fragment Ligation: During DNA replication, LIG1 seals the nicks between Okazaki fragments on the lagging strand, ensuring continuous DNA synthesis.
- Long-Patch Base Excision Repair (LP-BER): LIG1 participates in repair of oxidative DNA damage and single-strand breaks through the LP-BER pathway.
- Nucleotide Excision Repair (NER): LIG1 contributes to repair of UV-induced DNA lesions and other bulky adducts.
- DNA Replication Fidelity: By sealing nicks during replication, LIG1 maintains genomic stability.
DNA damage accumulation is a hallmark of aging and neurodegenerative diseases. LIG1 dysfunction may contribute to:
- Alzheimer's Disease (AD): Neurons are particularly vulnerable to DNA damage due to their high metabolic activity and post-mitotic state. Impaired LIG1 function may lead to accumulation of DNA strand breaks, contributing to neuronal dysfunction and death.
- Parkinson's Disease (PD): Oxidative stress in dopaminergic neurons can cause DNA damage. LIG1 deficiency may impair repair mechanisms, accelerating neurodegeneration in the substantia nigra.
- Amyotrophic Lateral Sclerosis (ALS): Motor neurons exhibit increased sensitivity to DNA damage. LIG1 polymorphisms may modify disease progression.
- Aging: Age-related decline in LIG1 activity correlates with accumulated DNA damage in neurons.
**Symbol:** LIG1
**Full Name:** DNA Ligase 1
**Chromosome:** 19q13.3
**Molecular Weight:** ~102 kDa
**Protein Class:** DNA Replication/Repair Enzyme
**Aliases:** CDC9, Ligase I
LIG1 contains an N-terminal region that interacts with PCNA (Proliferating Cell Nuclear Antigen), which tethers it to the replication fork. The catalytic core contains the adenylation domain and the DNA-binding domain, essential for nick sealing activity.
- DNA Repair Enhancement: Small molecules that enhance LIG1 activity or stability may protect neurons from DNA damage-induced death.
- Gene Therapy: Viral vectors delivering functional LIG1 could potentially restore DNA repair capacity in affected neurons.
- Combination Therapies: LIG1 activators may synergize with antioxidants to combat oxidative DNA damage in neurodegenerative diseases.
- PCNA: Direct interaction targets LIG1 to replication foci
- RPA: Coordinates DNA replication with repair
- FEN1: Works together in long-patch DNA repair
- POL β: Partner in base excision repair pathway
The study of Lig1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- DNA ligase I deficiency results in reduced neuronal survival
- LIG1 and neurodegeneration: emerging connections
- DNA damage repair in Alzheimer's disease
- Base excision repair in neuronal cells
- LIG1 polymorphisms and Parkinson's disease risk